α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial
/in Dendritic Cells, Glioblastoma, International Publications /von 2012-12-27 / BMC Cancer 2012 Dec;12:623Gemcitabine and cisplatin combined with regional hyperthermia as second-line treatment in patients with gemcitabine-refractory advanced pancreatic cancer
/in Hyperthermia, International Publications, Pancreatic Cancer /von 2012-12-17 / Int J Hyperthermia 2013;29(1):8-16The immunological response and post-treatment survival of DC-vaccinated melanoma patients are associated with increased Th1/Th17 and reduced Th3 cytokine responses
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2012-12-15 / Cancer Immunol. Immunother. 2013 Apr;62(4):761-72Short-term hyperthermia promotes the sensitivity of MCF-7 human breast cancer cells to paclitaxel
/in Breast Cancer, Hyperthermia, International Publications /von 2012-12-11 / Biol. Pharm. Bull. 2013;36(3):376-83Enhanced therapeutic effect of B cell-depleting anti-CD20 antibodies upon combination with in-situ dendritic cell vaccination in advanced lymphoma
/in Dendritic Cells, International Publications, Malignant Lymphoma /von 2012-12-01 / Clin. Exp. Immunol. 2012 Dec;170(3):291-9Immunotherapy with tumor vaccines for the treatment of malignant gliomas
/in Glioblastoma, International Publications /von 2012-12-01 / Curr Drug Discov Technol 2012 Dec;9(4):237-55
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de